← back to search

Nancy Greenland

University of California, San Francisco · US
Area of research
Pulmonary and Respiratory Medicine · Surgery
Research interest
Research interests include Prostate Cancer Treatment and Research, Prostate Cancer Diagnosis and Treatment, Bladder and Urothelial Cancer Treatments, and Radiopharmaceutical Chemistry and Applications.
h-index
11
citations
445
works
87
NIH funding
primary concept
email

Recent publications

Renal tumors harboring FLCN mutations: Case series from clinical practice
Human Pathology 2026cited by 0position: middledoi
Effective Treatment of Disseminated Prostate Cancer Using CD46-Targeted 225Ac Therapy
Clinical Cancer Research 2025cited by 9position: middledoi
International Society of Urological Pathology Consensus on Cancer Precursor Lesions. Working Group 1
The American Journal of Surgical Pathology 2025cited by 9position: middledoi
The Genitourinary Pathology Society and International Society of Urological Pathology Joint Expert Consultation Recommendations on intraductal carcinoma of the prostate
Histopathology 2025cited by 6position: middledoi
Development of CD46 targeted alpha theranostics in prostate cancer using <sup>134</sup>Ce/<sup>225</sup>Ac-Macropa-PEG<sub>4</sub>-YS5
Theranostics 2024cited by 27position: middledoi
Chronic lung allograft dysfunction small airways reveal a lymphocytic inflammation gene signature
American Journal of Transplantation 2020cited by 40position: middledoi
Targeting CD74 in multiple myeloma with the novel, site-specific antibody-drug conjugate STRO-001
Oncotarget 2018cited by 52position: middledoi
Genomic profiling of malignant phyllodes tumors reveals aberrations in FGFR1 and PI-3 kinase/RAS signaling pathways and provides insights into intratumoral heterogeneity
Modern Pathology 2016cited by 76position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Anju Wadhwa · University of California, San Francisco2 papers (2024–2025)Jiang He · Beijing Zhenxing Metrology & Measurement Institute2 papers (2024–2025)Anil P. Bidkar · University of California, San Francisco2 papers (2024–2025)Jonathan Chou · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2024–2025)Scott Bidlingmaier · University of California, San Francisco2 papers (2024–2025)Kondapa Naidu Bobba · University of California, San Francisco2 papers (2024–2025)Bradley A. Stohr · City College of San Francisco2 papers (2016–2026)David M. Wilson · University of California, San Francisco2 papers (2024–2025)Niranjan Meher · National Institute of Pharmaceutical Education and Research2 papers (2024–2025)Henry F. VanBrocklin · University of California, San Francisco2 papers (2024–2025)Youngho Seo · University of California, San Francisco2 papers (2024–2025)Rahul Aggarwal · UCSF Helen Diller Family Comprehensive Cancer Center2 papers (2024–2025)Robert R. Flavell · University of California, San Francisco2 papers (2024–2025)Jeffrey A. Golden · University of California, San Francisco1 papers (2020–2020)Shannon Matheny · Sutro Biopharma (United States)1 papers (2018–2018)Rupal Shah · University of California, San Francisco1 papers (2020–2020)Yunn‐Yi Chen · University of California, San Francisco1 papers (2016–2016) · 1 papers (2018–2018)Adam Oskowitz · University of California, San Francisco1 papers (2025–2025)Chaz Langelier · University of California, San Francisco1 papers (2020–2020)